Guerrero-Ramos, F, Chang, S, Dickstein, RJ, Jayram, G, Johnson, S, Joshi, S, Liu, JJ, Lotan, Y, Marcq, G, Satkunasivam, R, Schuckman, A, Steinberg, G, Taylor, J, Linback, T, Pruthi, R, Cheung, A, Tosone, C, Kamat, AM, Palou, J. A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

Briones, JR, Guerrero-Ramos, F, Mercade, A, Abadia, IB, Rodriguez, RM, Alcaraz, A, Legaz, MM, Lozano, F, Arrabal, M, Cardo, AL, Rodriguez, VG, Velasco, JC, Liesa, MS, Pareja, CF, Espilez, R, Valcárcel, IG, Zalabardo, DS, Esquinas, C, Mengual, L, Borque-Fernando, N, Esteban, LM, Palou, J, Witjes, JA, Pineiro, LM. External validation of Uromonitor® as a biomarker for optimization of NMIBC follow up by the CUETO group; evaluation-CUETO study. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

Afferi, L, Margue, G, Toribio-Vázquez, C, Baekelandt, L, Goujon, A, Ozalevli, M, Checcucci, E, Gugerli, A, Siech, C, Vásquez, JL, Melsert, BM, Mertens, LS, Liatsikos, E, Somani, BK, Galliol, A, Pradere, B, Breda, A, Whitburn, J, Rangel, E. Regulations on pregnancy and parenthood during urology residency in European countries. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

Van Uitert, A, 't Hoen, LA, Bussmann, M, Bezuidenhout, C, Ribal, M, Canfield, SE, Yuan, Y, Omar, M, Castagnetti, M, Burgu, B, Kelly, F, Quaedackers, J, Rawashdeh, Y, Silay, S, Bujon, A, Bogaert, G, Pakkasjarvi, N, Skott, M, Kennedy, U, Gnech, M, Radmayr, C. Annual updates of the European Association of Urology (EAU) / European Society for Paediatric Urology (ESPU) Pediatric Urology Guidelines: Are large-language models better than the usual structured methodology?. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).